The TMS platform is trusted by 500+ fleets across North America, creating 90% driver retention with proven gains in ...
Medicare covers transcranial magnetic stimulation (TMS) but only as treatment for severe major depressive disorder (MDD). There are additional eligibility requirements you must meet and out-of-pocket ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...
Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate specific areas of the brain. It’s shown promise in treating obsessive-compulsive disorder (OCD), including cases that may not ...
While the Covid-19 pandemic wreaked havoc in many ways, it also did a good thing: making the importance of mental health visible. Several specialists agree that, after the virus, the next pandemic ...
TORONTO, March 6, 2023 /PRNewswire/ - Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), announces today that it is embarking on a comprehensive restructuring plan (the ...